‌

US Patent 10905701 Compositions and methods for inhibiting arginase activity

Patent 10905701 was granted and assigned to Calithera Biosciences on February, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Calithera Biosciences

0

Current Assignee

Calithera Biosciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Weiqun Li0

Matthew I. Gross0

Susanne M. Steggerda0

Date of Patent

February 2, 2021

0

Patent Application Number

165254030

Date Filed

July 29, 2019

0

Patent Primary Examiner

Shirley V Gembeh

0

Patent abstract

The invention relates to methods of treating cancer, with a combination of an arginase inhibitor and a chemotherapeutic agent. The invention further relates to methods of assessing efficacy of a cancer treatment by measuring arginine levels in a tumor.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10905701 Compositions and methods for inhibiting arginase activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.